c-ABL-IN-3

• CAS Number:

  2626934-64-1

• UNSPSC Description:

  c-ABL-IN-3 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-3 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 50)[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/c-abl-in-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C(C=C1)=CN(C2=CN=CN=C2)C1=O)NC3=CC=C(OC(F)(F)F)C=C3

• Molecular Weight:

  376.29

• References & Citations:

  [1]Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported